Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A study published in JAMA Psychiatry enrolled ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Bose, Priyom. (2025, February 13). Low-dose semaglutide reduces alcohol consumption and cravings ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of ...

At 9 weeks, semaglutide led to fewer grams of alcohol consumed during a laboratory self-administration task (β= -0.48, 95% CI -0.85 to -0.11, P=0.01) and lower peak breath alcohol concentration ...

Semaglutide (the active ingredient in Ozempic and Wegovy) and similar GLP-1 drugs are far more effective at helping people lose weight than diet and exercise alone. But some scientists have also ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

Semaglutide and related weight-loss medications, known as GLP-1 agonists, may slow biological ageing, reduce inflammation, improve cognitive function and gut health, and reduce alcohol use in people ...

Alcohol is killing more women than ever before. As the gender gap in drinking narrows, alcohol-related complications in women are rising. From immune system disorders to breast cancer, here’s ...